RHY — Rhythm Biosciences Share News
0.000.00%
- AU$22.94m
- AU$19.74m
- AU$1.74m
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt
Brief: Rhythm Biosciences Enters ColoSTAT Services Agreement With 4Cyte Pathology
Rhythm Biosciences set for best week in nearly 6 years
Australia's Rhythm Biosciences at nearly 6-month high on multi-year supply agreement
Brief: Rhythm Biosciences Signs Manufacturing Agreement
Rhythm Biosciences gains on Australian Genome Research Facility partnership
Brief: Rhythm Biosciences Biosciences Secures Strategic Alliance With AGRF
Brief: Rhythm Biosciences Secures Strategic Us Partnership With Cancer IQ
Australia's Rhythm Biosciences set for best day in four months on commercialisation of cancer test
Brief: Rhythm Biosciences Says CFO Todd Perkinson To Leave
Australia's Rhythm Biosciences gains on cancer test collaboration
Brief: Rhythm Biosciences Entered Collaboration With Southern Hub Research Team, Royal Surrey NHS Foundation Trust
Brief: Rhythm Biosciences Enters A Us Marketing Partnership With Catch Bio
Brief: Rhythm Biosciences Says Gavin Fox-Smith Appointed Chair
Brief: Rhythm Biosciences Announces Strategic Partnership With Know Your Lemons Foundation
Brief: Rhythm Biosciences To Raise Up To A$3.75 Million At A$0.09 Per Share